{"transactions":[{"id":1835250,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-07-05T20:23:25.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal annual installments beginning on July 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal annual installments beginning on July 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."}],"balance_after":45000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-041060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919123041060/doc4.xml","form_type":"4"}},{"id":1835249,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:23:25.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5407,"price":10.37,"value":56070.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4."}],"balance_after":9593,"source":{"system":"sec-edgar","filing":"0001209191-23-041060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919123041060/doc4.xml","form_type":"4"}},{"id":1835248,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:23:25.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-23-041060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919123041060/doc4.xml","form_type":"4"}},{"id":2032190,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-03T21:58:51.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-006982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919123006982/doc4.xml","form_type":"4"}},{"id":2032189,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-03T21:58:51.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date."}],"balance_after":105000,"derivative":{"exercise_price":16.97,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-23-006982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919123006982/doc4.xml","form_type":"4"}},{"id":2213967,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-05T21:01:25.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal annual installments beginning on July 1, 2023, subject to the Reporting\nPerson's continuous service with the Issuer as of the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying these restricted stock units vest in four equal annual installments beginning on July 1, 2023, subject to the Reporting\nPerson's continuous service with the Issuer as of the applicable vesting date."}],"balance_after":60000,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-040787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919122040787/doc4.xml","form_type":"4"}},{"id":2213966,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-07-05T21:01:25.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on July 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."}],"balance_after":210000,"derivative":{"exercise_price":13.83,"expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001209191-22-040787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557746/000120919122040787/doc4.xml","form_type":"4"}},{"id":2394162,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2022-02-15T16:48:04.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":320,"price":15.8,"value":5056.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":35740,"source":{"system":"sec-edgar","filing":"0001104659-22-023838","document":"tm226876-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922023838/tm226876-1_4seq1.xml","form_type":"4"}},{"id":2420991,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-31T16:14:12.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":11300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2022."}],"balance_after":11300,"derivative":{"exercise_price":14.44,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":11300},"source":{"system":"sec-edgar","filing":"0001104659-22-009553","document":"tm224882-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009553/tm224882-3_4seq1.xml","form_type":"4"}},{"id":2420990,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2022-01-31T16:14:12.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2022."}],"balance_after":36060,"source":{"system":"sec-edgar","filing":"0001104659-22-009553","document":"tm224882-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009553/tm224882-3_4seq1.xml","form_type":"4"}},{"id":2448289,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2022-01-04T16:14:21.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":2455,"price":16.29,"value":39991.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":29460,"source":{"system":"sec-edgar","filing":"0001104659-22-000909","document":"tm221409d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922000909/tm221409d1_4.xml","form_type":"4"}},{"id":2510325,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2021-11-16T16:58:20.000Z","date":"2021-11-12","kind":"tax_withholding","acquired":false,"shares":319,"price":19.04,"value":6073.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":31915,"source":{"system":"sec-edgar","filing":"0001104659-21-140028","document":"tm2132981-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921140028/tm2132981-1_4seq1.xml","form_type":"4"}},{"id":2603556,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2021-08-13T19:01:26.000Z","date":"2021-08-12","kind":"tax_withholding","acquired":false,"shares":319,"price":15.28,"value":4874.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":32234,"source":{"system":"sec-edgar","filing":"0001104659-21-105301","document":"tm2125095-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921105301/tm2125095-1_4seq1.xml","form_type":"4"}},{"id":2714246,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2021-05-13T19:01:04.000Z","date":"2021-05-12","kind":"tax_withholding","acquired":false,"shares":319,"price":17.75,"value":5662.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":32553,"source":{"system":"sec-edgar","filing":"0001104659-21-066143","document":"tm2116297d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921066143/tm2116297d1_4.xml","form_type":"4"}},{"id":2854003,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2021-02-17T19:00:41.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":319,"price":31.32,"value":9991.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":32872,"source":{"system":"sec-edgar","filing":"0001104659-21-024922","document":"tm216932d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921024922/tm216932d1_4.xml","form_type":"4"}},{"id":2894999,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Option to Purchase Common Stock","published_at":"2021-01-26T19:00:37.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":19700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2021."}],"balance_after":19700,"derivative":{"exercise_price":29.46,"expiration_date":"2031-01-22","underlying":"Common Stock","underlying_shares":19700},"source":{"system":"sec-edgar","filing":"0001104659-21-007776","document":"tm214232d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921007776/tm214232d1_4.xml","form_type":"4"}},{"id":2894998,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2021-01-26T19:00:37.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":12600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2021."}],"balance_after":33191,"source":{"system":"sec-edgar","filing":"0001104659-21-007776","document":"tm214232d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921007776/tm214232d1_4.xml","form_type":"4"}},{"id":2919916,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2021-01-05T19:00:29.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":706,"price":24.7,"value":17438.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":20591,"source":{"system":"sec-edgar","filing":"0001104659-21-001115","document":"tm211606-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921001115/tm211606-1_4seq1.xml","form_type":"4"}},{"id":2979519,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2020-11-16T19:00:21.000Z","date":"2020-11-12","kind":"tax_withholding","acquired":false,"shares":319,"price":38.52,"value":12287.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":21297,"source":{"system":"sec-edgar","filing":"0001104659-20-125980","document":"tm2036091d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920125980/tm2036091d1_4.xml","form_type":"4"}},{"id":3057121,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2020-08-14T19:00:32.000Z","date":"2020-08-12","kind":"tax_withholding","acquired":false,"shares":319,"price":53.44,"value":17047.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":21616,"source":{"system":"sec-edgar","filing":"0001104659-20-095692","document":"tm2027604d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920095692/tm2027604d1_4.xml","form_type":"4"}},{"id":3148682,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2020-05-14T19:00:28.000Z","date":"2020-05-12","kind":"tax_withholding","acquired":false,"shares":319,"price":89.05,"value":28406.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":21935,"source":{"system":"sec-edgar","filing":"0001104659-20-061768","document":"tm2019757-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920061768/tm2019757-1_4.xml","form_type":"4"}},{"id":3270266,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2020-02-14T19:00:27.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":319,"price":96.74,"value":30860.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":22254,"source":{"system":"sec-edgar","filing":"0001104659-20-022117","document":"tm208156d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920022117/tm208156d1_form4.xml","form_type":"4"}},{"id":3301187,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Option to Purchase Common Stock","published_at":"2020-01-27T19:04:28.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2020."}],"balance_after":6900,"derivative":{"exercise_price":99.66,"expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0001104659-20-007263","document":"tm205922d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920007263/tm205922d4_4.xml","form_type":"4"}},{"id":3301186,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2020-01-27T19:04:28.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2020."}],"balance_after":22573,"source":{"system":"sec-edgar","filing":"0001104659-20-007263","document":"tm205922d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920007263/tm205922d4_4.xml","form_type":"4"}},{"id":3322315,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Option to Purchase Common Stock","published_at":"2020-01-03T19:00:51.000Z","date":"2019-12-31","kind":"exercise","acquired":false,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award is subject to a four-year vesting period, with 25% of shares subject to the award vesting and becoming exercisable in an initial installment on the anniversary of the Vesting Start Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Start Date was February 12, 2018."}],"balance_after":20779,"derivative":{"exercise_price":54.63,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":262},"source":{"system":"sec-edgar","filing":"0001104659-20-001084","document":"tm201209d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001084/tm201209d1_4.xml","form_type":"4"}},{"id":3322314,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:51.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":349,"price":123.92,"value":43248.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":18373,"source":{"system":"sec-edgar","filing":"0001104659-20-001084","document":"tm201209d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001084/tm201209d1_4.xml","form_type":"4"}},{"id":3322313,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:51.000Z","date":"2019-12-31","kind":"sale","acquired":false,"shares":262,"price":125,"value":32750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":18722,"source":{"system":"sec-edgar","filing":"0001104659-20-001084","document":"tm201209d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001084/tm201209d1_4.xml","form_type":"4"}},{"id":3322312,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:51.000Z","date":"2019-12-31","kind":"exercise","acquired":true,"shares":262,"price":54.63,"value":14313.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":18984,"source":{"system":"sec-edgar","filing":"0001104659-20-001084","document":"tm201209d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001084/tm201209d1_4.xml","form_type":"4"}},{"id":3329664,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-30T19:00:45.000Z","date":"2019-12-26","kind":"exercise","acquired":false,"shares":54,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award is subject to a four-year vesting period, with 25% of shares subject to the award vesting and becoming exercisable in an initial installment on the anniversary of the Vesting Start Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Start Date was February 12, 2018."}],"balance_after":21041,"derivative":{"exercise_price":54.63,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":54},"source":{"system":"sec-edgar","filing":"0001104659-19-076862","document":"tm1929364d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465919076862/tm1929364d1_4.xml","form_type":"4"}},{"id":3329663,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2019-12-30T19:00:45.000Z","date":"2019-12-26","kind":"sale","acquired":false,"shares":54,"price":125,"value":6750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":18722,"source":{"system":"sec-edgar","filing":"0001104659-19-076862","document":"tm1929364d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465919076862/tm1929364d1_4.xml","form_type":"4"}},{"id":3329662,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2019-12-30T19:00:45.000Z","date":"2019-12-26","kind":"exercise","acquired":true,"shares":54,"price":54.63,"value":2950.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":18776,"source":{"system":"sec-edgar","filing":"0001104659-19-076862","document":"tm1929364d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465919076862/tm1929364d1_4.xml","form_type":"4"}},{"id":3350739,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-05T19:00:28.000Z","date":"2019-12-03","kind":"exercise","acquired":false,"shares":80,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"cash exercise\" of stock options pursuant to which the reporting person paid to the Issuer the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award is subject to a four-year vesting period, with 25% of shares subject to the award vesting and becoming exercisable in an initial installment on the anniversary of the Vesting Start Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Start Date was February 12, 2018."}],"balance_after":21095,"derivative":{"exercise_price":54.63,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":80},"source":{"system":"sec-edgar","filing":"0001104659-19-070281","document":"tm1924493d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465919070281/tm1924493d2_4.xml","form_type":"4"}},{"id":3350738,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2019-12-05T19:00:28.000Z","date":"2019-12-03","kind":"exercise","acquired":true,"shares":80,"price":54.63,"value":4370.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"cash exercise\" of stock options pursuant to which the reporting person paid to the Issuer the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."}],"balance_after":18722,"source":{"system":"sec-edgar","filing":"0001104659-19-070281","document":"tm1924493d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465919070281/tm1924493d2_4.xml","form_type":"4"}},{"id":3371094,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2019-11-14T19:00:35.000Z","date":"2019-11-12","kind":"tax_withholding","acquired":false,"shares":319,"price":83.02,"value":26483.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":18642,"source":{"system":"sec-edgar","filing":"0001104659-19-064410","document":"tm1922797d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465919064410/tm1922797d1_4.xml","form_type":"4"}},{"id":3438584,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2019-08-14T19:01:10.000Z","date":"2019-08-12","kind":"tax_withholding","acquired":false,"shares":319,"price":65.89,"value":21018.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":18961,"source":{"system":"sec-edgar","filing":"0001144204-19-040154","document":"tv527531_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419040154/tv527531_4.xml","form_type":"4"}},{"id":3527478,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2019-05-14T19:00:18.000Z","date":"2019-05-12","kind":"tax_withholding","acquired":false,"shares":319,"price":86.66,"value":27644.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":19280,"source":{"system":"sec-edgar","filing":"0001144204-19-026105","document":"tv521399_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419026105/tv521399_4.xml","form_type":"4"}},{"id":3551379,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Option to Purchase Common Stock","published_at":"2019-04-22T19:01:57.000Z","date":"2019-04-18","kind":"exercise","acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"cash exercise\" of stock options pursuant to which the reporting person paid to the Issuer the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award is subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date was February 12, 2018."}],"balance_after":21175,"derivative":{"exercise_price":54.63,"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001144204-19-020605","document":"tv519304_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419020605/tv519304_4.xml","form_type":"4"}},{"id":3551378,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2019-04-22T19:01:57.000Z","date":"2019-04-18","kind":"exercise","acquired":true,"shares":1750,"price":54.63,"value":95602.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"cash exercise\" of stock options pursuant to which the reporting person paid to the Issuer the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction."}],"balance_after":19599,"source":{"system":"sec-edgar","filing":"0001144204-19-020605","document":"tv519304_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419020605/tv519304_4.xml","form_type":"4"}},{"id":3656236,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2019-02-14T19:00:28.000Z","date":"2019-02-12","kind":"tax_withholding","acquired":false,"shares":1276,"price":111.05,"value":141699.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":17849,"source":{"system":"sec-edgar","filing":"0001144204-19-008417","document":"tv513467_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419008417/tv513467_4.xml","form_type":"4"}},{"id":3691680,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-18T19:00:43.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2019."}],"balance_after":6700,"derivative":{"exercise_price":110.8,"expiration_date":"2029-01-16","underlying":"Common Stock","underlying_shares":6700},"source":{"system":"sec-edgar","filing":"0001144204-19-002137","document":"tv511177_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002137/tv511177_4.xml","form_type":"4"}},{"id":3691679,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":111601,"kind":"person","name":"Cawkwell Gail","position":1,"cik":"0001761167","reported_name":"Cawkwell Gail","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Med Affairs, Safety & PV"}}],"security":"Common Stock","published_at":"2019-01-18T19:00:43.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2019."}],"balance_after":19125,"source":{"system":"sec-edgar","filing":"0001144204-19-002137","document":"tv511177_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002137/tv511177_4.xml","form_type":"4"}}]}